Aflac
Supplemental health and life insurance provider
AVP – GI Strategic Analytics
+ Annual bonus + Company stock purchase opportunity
At least 60% of the work week must be in the New York office; the remaining time may be worked from home within the continental United States.
About the job
- Strong business acumen and understanding of investment concepts and performance drivers across asset classes.
- Exceptional communication and storytelling skills.
- Demonstrated success operating in high-expectation, executive-facing environments.
- Proven ability to lead complex analytics, reporting, or business intelligence initiatives end-to-end.
- Strong organizational skills and ability to manage multiple priorities in a fast-paced environment.
- High attention to detail and commitment to quality.
- A bachelor's degree in Finance, Macroeconomics, Statistics, Accounting, Mathematics, or a related field.
- At least 7 years of experience in asset management, investment analytics, financial services, or a related field.
- Experience developing board-level or senior executive presentations, with a strong focus on structured thinking and clear, audience-appropriate communication.
- Experience with business intelligence and analytics tools such as Power BI, Alteryx, or similar.
- An equivalent combination of education and experience may be accepted.
- Lead development of board and senior leadership presentations by synthesizing complex investment, financial, and strategic information into clear, concise, and decision-oriented narratives.
- Frame key business questions, insights, and recommendations to structure materials, drive discussion, align stakeholders, and support executive decision-making.
- Own end-to-end structuring and content development, including organizing materials, refining exhibits, and tailoring outputs to the audience and context.
- Oversee performance and regular portfolio reporting to support senior leadership decision-making and investment committee governance.
- Drive the evolution of business intelligence capabilities by incorporating automation, advanced analytics, and artificial intelligence-driven enhancements into reporting workflows to improve scalability and speed to insight.
- Promote consistent metric definitions, data governance, and adoption of self-service analytics.
- Collaborate with information technology and data teams on governed data models and scalable reporting solutions.
- Prioritize work, guide execution, and elevate team output as a leader within business intelligence.
- Coach and mentor team members, raising standards for analytics, structured communication, audience-tailored messaging, and presentation quality.
- Serve as a trusted partner to investment teams, investor relations, investment accounting, and senior leadership.
- Partner with the Head of Business Intelligence to support capability development and team effectiveness.
- Lead peer benchmarking, competitive intelligence, and market analysis efforts.
- Provide analytical support for strategic initiatives and business planning.
- Identify trends, risks, and opportunities through data and external insights.
- Perform other duties as assigned.
- Exposure to data automation, data architecture, or artificial intelligence-enabled analytics use cases.
About the company
Aflac provides supplemental health and life insurance products to individuals and families, operating mainly in two regions: Aflac Japan and Aflac U.S. Its policies are designed to cover out-of-pocket costs from health events and income loss, including cancer, critical illness, accidents, hospital stays, and life events. These benefits are paid directly to policyholders to help manage medical expenses not fully covered by primary insurance. The products are distributed through a network of independent agents, brokers, and financial advisors, enabling a high-volume, low-premium model that supports a large, stable customer base and ongoing revenue. Japan is its largest market, and the company uses this broad distribution and scale to differentiate itself from competitors. The goal is to provide straightforward financial protection against unexpected health-related costs while expanding its presence in the U.S. and Japanese markets.
Company Size
10,001+
Company Stage
IPO
Headquarters
Columbus, Georgia
Founded
1955
Get referred to Aflac
See people who can refer or advise you
Simplify's Take
What believers are saying
- August 6, 2026 results beat on earnings quality, with $825 million net income.
- Japan sales rose 7% in first half 2026, helped by Tsumitasu and Anshin Palette.
- Aflac U.S. grew 2.6%, led by group voluntary, dental, and vision products.
What critics are saying
- June 2026 Aflac Japan cyberattack exposed millions, inviting class actions and regulatory penalties.
- Q2 2026 revenues fell 1.0%, while FX and Japan comps distorted results.
- Japan Post Holdings still controls roughly 10% and trimmed shares through September 2026.
What makes Aflac unique
- Japan and U.S. supplemental insurance distribution creates recurring, sticky employer and agent channels.
- Aflac Japan still leads cancer and medical supplemental coverage, anchored by Miraito and Tsumitasu.
- The balance sheet generates massive buybacks and dividends, returning $1.3 billion in Q2 2026.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Paid Holidays
Hybrid Work Options
Remote Work Options
Growth & Insights and Company News
6 month growth
↓ -2%1 year growth
↓ -2%2 year growth
↓ -2%On September 11, during Mad Money's lightning round, Jim Cramer described Aflac Incorporated as "not great, not bad," noting the stock isn't expensive but lacks significant growth potential. He said the company has limited downside risk at current levels. Aflac reported second-quarter net earnings of $825 million, up from $599 million the previous year. The company returned $1.3 billion to shareholders through $983 million in share repurchases and $309 million in dividends. However, total revenues declined to $4.1 billion, pressured by foreign exchange headwinds. Aflac Japan's adjusted revenues dropped 12.6% in dollar terms to $2.2 billion due to a weaker yen. According to Insider Monkey's database, 39 hedge funds held stakes in Aflac during the second quarter.
Japan Post Holdings has acquired approximately 63% of AFLAC Inc., purchasing around 50.6 million shares in a transaction valued at an estimated $5.8 billion. The Japanese entity is acting as trustee of a trust holding the stake. The acquisition gives Japan Post Holdings significant influence over AFLAC's corporate governance, including board appointments and strategic direction. AFLAC's share price rose modestly by 0.8% following the disclosure, closing at $117.50. The transaction was disclosed via Form 4 filing as of 10 September 2026. With AFLAC's market capitalisation standing at approximately $9.3 billion, the stake positions Japan Post Holdings amongst the insurer's largest shareholders. The cross-border ownership structure may attract regulatory scrutiny from both US and Japanese authorities. Institutional investors are advised to monitor the trust's proxy voting behaviour and governance decisions.
Aflac shares have underperformed the broader insurance sector, rising just 1.7% over the past three months compared to a 12.4% gain for the iShares U.S. Insurance ETF. The Columbus, Georgia-based supplemental insurance provider, valued at $61.7 billion, trades 10% below its July 52-week high of $130.22. The company's recent second-quarter results disappointed investors, with adjusted earnings of $1.75 missing expectations and revenue falling 1% year-over-year to $4.1 billion. Higher benefits and claims pressured profitability at Aflac U.S., whilst operations in Japan showed signs of slowing. Analysts have grown cautious about Aflac's growth prospects, questioning whether its core businesses can deliver sufficient expansion beyond share buybacks. The stock has dipped below its 50-day moving average, suggesting weakened near-term momentum despite holding above its 200-day average for most of the past year.
Aflac's second quarter results disappointed investors despite meeting Wall Street expectations, with revenue declining 6.9% year-on-year to $4.22 billion. The insurance giant attributed the sales drop largely to difficult comparisons following last year's launch of its Miraito cancer insurance product in Japan. Chief Executive Daniel Amos said new Japanese offerings like Tsumitasu and Anshin Palette generated solid growth. US sales grew modestly, supported by group voluntary products and network dental and vision offerings. During the earnings call, analysts pressed management on several key issues. Questions focused on the sustainability of asset repositioning efforts, appetite for larger acquisitions, sequential declines in Japanese medical sales, and the impact of inflation on policy lapse rates. Amos said Aflac remains open to strategic acquisitions but will maintain discipline, favouring smaller deals that fit operationally and financially.
Aflac reported second-quarter revenue of $4.22 billion, meeting Wall Street expectations but declining 6.9% year on year. Adjusted earnings per share of $1.75 also met analyst estimates. The supplemental insurance provider attributed the revenue decline to tough comparisons in Japan following last year's cancer insurance product launch and shifting consumer preferences. However, CEO Daniel Amos highlighted solid growth from new offerings including Tsumitasu and Anshin Palette. In the US, group voluntary products and network dental and vision sales showed strength, with dental and vision product sales rising 47%. The company maintained expense discipline despite inflationary pressures. Looking ahead, Aflac plans to focus on product innovation in Japan, continued US group product momentum, and enhanced capital management. Management emphasised its commitment to dividend growth and share repurchases.